Cargando…

Safety and efficacy of pilocarpine, cevimeline, and diquafosol compared to artificial tears for the treatment of dry eye: protocol for a systematic review

BACKGROUND: Dry eye disease (DED) is a condition that compromises the ocular surface and affects millions of people around the world. In recent years, a scheme has been proposed for the treatment of DED, with the use of artificial tear being the mainstay of treatment. In this scheme, the use of secr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serrano-Robles, José Gerardo, Pérez Vázquez, Ana Karen, Navas, Alejandro, Graue-Hernandez, Enrique O., Ramirez-Miranda, Arturo, Kahuam-López, Nicolás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148479/ https://www.ncbi.nlm.nih.gov/pubmed/35643581 http://dx.doi.org/10.1186/s13643-022-01979-4

Ejemplares similares

Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials
por: Zhao, Xinyu, et al.
Publicado: (2017)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
por: Miyake, Hideki, et al.
Publicado: (2016)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease
por: Mun, Yongseok, et al.
Publicado: (2018)

Neuropharmacology of Cevimeline and Muscarinic Drugs—Focus on Cognition and Neurodegeneration
por: Oleksak, Patrik, et al.
Publicado: (2021)

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano, Shiro, et al.
Publicado: (2017)

Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
por: Nagahara, Yukiko, et al.
Publicado: (2015)

Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study
por: Fukuoka, Shima, et al.
Publicado: (2019)

Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
por: So, Ha Rim, et al.
Publicado: (2023)

3% diquafosol sodium eye drops in Chinese patients with dry eye: a phase IV study
por: Wang, Wenying, et al.
Publicado: (2023)

Editorial: Dry eye disease syndrome
por: Navas, Alejandro, et al.
Publicado: (2023)

Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study
por: Lee, Kwan Bok, et al.
Publicado: (2017)

Dry eye: why artificial tears are not always the answer
por: Kim, Minji, et al.
Publicado: (2021)

Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery
por: Yamazaki, Kenichiro, et al.
Publicado: (2022)

Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens
por: Yang, Yuanfang, et al.
Publicado: (2023)

Personalized Management of Dry Eye Disease: Beyond Artificial Tears
por: Matossian, Cynthia, et al.
Publicado: (2022)

Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials
por: Liu, Shuang, et al.
Publicado: (2023)

Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution
por: Ishikawa, Sho, et al.
Publicado: (2023)

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
por: Takamura, Etsuko, et al.
Publicado: (2012)

Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
por: Labetoulle, Marc, et al.
Publicado: (2022)

Suspected cholinergic toxicity due to cevimeline hydrochloride and Bacopa monnieri interaction: a case report
por: Acquarulo, Blake, et al.
Publicado: (2022)

Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery
por: Inoue, Yasushi, et al.
Publicado: (2016)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2019)

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)

Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
por: Ohashi, Yuichi, et al.
Publicado: (2019)

Effect of artificial tears on dynamic optical quality in patients with dry eye disease
por: Wei, Zhenyu, et al.
Publicado: (2022)

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease
por: Nasser, Linda, et al.
Publicado: (2018)

Significant Increase in Salivary Substance P Level after a Single Oral Dose of Cevimeline in Humans
por: Suzuki, Yosuke, et al.
Publicado: (2013)

Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
por: Miyake, Kensaku, et al.
Publicado: (2017)

The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study
por: Chen, Jiayan, et al.
Publicado: (2023)

Tear proteomics in dry eye disease
por: Kannan, Ramaraj, et al.
Publicado: (2023)

Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction
por: Sindt, Christine W, et al.
Publicado: (2013)

Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model
por: She, Yujing, et al.
Publicado: (2015)

The efficacy of ocular surface assessment approaches in evaluating dry eye treatment with artificial tears
por: Szczesna-Iskander, Dorota H., et al.
Publicado: (2022)

Artificial intelligence to estimate the tear film breakup time and diagnose dry eye disease
por: Shimizu, Eisuke, et al.
Publicado: (2023)

Eserine and Pilocarpine in the Treatment of Eye Disease
Publicado: (1878)

Value of Jaborandi and Pilocarpine in Eye Diseases
Publicado: (1882)

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
por: Torkildsen, Gail, et al.
Publicado: (2017)

The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice Treated with Antiglaucoma Eye Medications
por: Yagi-Yaguchi, Yukari, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mstq6v08madja7gu7aq996aajk